Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction

(2010) M R Baneshi et al.   BRITISH JOURNAL OF CANCER

Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway

(2010) Lynn S. Adams et al.   CANCER RESEARCH

Estrogen Regulation and Physiopathologic Significance of Alternative Promoters in Breast Cancer

(2010) Martin Dutertre et al.   CANCER RESEARCH

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer

(2010) Sandra M. Swain et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines

(2009) Seok-Soo Byun et al.   CANCER LETTERS

Nm23-H1 regulates the proliferation and differentiation of the human chronic myeloid leukemia K562 cell line: A functional proteomics study

(2009) Lin Jin et al.   LIFE SCIENCES

Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation

(2008) Antoni D'Souza et al.   BRAIN RESEARCH

Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors

(2008) Alfonso Duenas-Gonzalez et al.   CANCER TREATMENT REVIEWS

Valproic Acid Induces Notch1 Signaling in Small Cell Lung Cancer Cells

(2008) Christopher S. Platta et al.   JOURNAL OF SURGICAL RESEARCH

Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells

(2008) L. Wu et al.   MOLECULAR CANCER THERAPEUTICS

Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells

(2007) Nicoletta Fortunati et al.   CANCER LETTERS